OraSure Technologies Inc (OSUR) Stock Price

OSURStock

$3.61+17.97%52W

Market Cap$248.98M

P/E—

PEG Ratio6.19

Div yield—

Beta1.09

OSUR Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)2.56%

Price vs S&P 500 (4W)-0.84%

PEG Ratio6.19

VGM Score59.44

P/CF (Annual)7.82x

Book Value / Share (Quarterly)$4.61

P/TBV (Annual)0.54x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-33.29%

Cash Flow / Share (Quarterly)$-0.70

Price vs S&P 500 (YTD)37.25%

Gross Margin (TTM)42.85%

Net Profit Margin (TTM)-43.70%

EPS (TTM)$-0.69

10-Day Avg Trading Volume0.47M

EPS Excl Extra (TTM)$-0.69

Revenue Growth (5Y)-7.70%

EPS (Annual)$-0.94

ROI (Annual)-20.16%

Gross Margin (Annual)42.22%

Net Profit Margin (5Y Avg)-14.30%

Cash / Share (Quarterly)$2.33

Revenue Growth QoQ (YoY)-1.93%

ROA (Last FY)-17.05%

Revenue Growth TTM (YoY)-18.86%

EBITD / Share (TTM)$-0.68

ROE (5Y Avg)-4.68%

Operating Margin (TTM)-48.06%

Cash Flow / Share (Annual)$-0.76

P/B Ratio0.78x

P/B Ratio (Quarterly)0.97x

Net Income / Employee (Annual)$-137,500

EV / Revenue (TTM)0.79x

Net Interest Coverage (TTM)-70.76x

ROA (TTM)-12.55%

EV / EBITDA (TTM)5.14x

EPS Incl Extra (Annual)$-0.94

Current Ratio (Annual)6.58x

Quick Ratio (Quarterly)7.54x

3-Month Avg Trading Volume0.52M

52-Week Price Return17.97%

EV / Free Cash Flow (Annual)-0.10x

Revenue / Employee (TTM)$224,800

Tangible BV / Share (Quarterly)$4.33

P/S Ratio (Annual)2.16x

Asset Turnover (Annual)0.29x

52-Week High$4.58

Operating Margin (5Y Avg)-16.00%

EPS Excl Extra (Annual)$-0.94

CapEx CAGR (5Y)-32.03%

Tangible BV CAGR (5Y)-3.31%

26-Week Price Return12.46%

Quick Ratio (Annual)5.67x

13-Week Price Return-6.72%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)8.88x

Enterprise Value$88.60M

Revenue / Share Growth (5Y)-9.26%

Asset Turnover (TTM)0.29x

Book Value / Share Growth (5Y)-2.73%

Revenue / Employee (Annual)$230,000

Inventory Turnover (Annual)2.04x

Pretax Margin (Annual)-56.15%

Cash / Share (Annual)$2.83

3-Month Return Std Dev45.22%

Gross Margin (5Y Avg)43.21%

Net Income / Employee (TTM)$-98,300

EBITDA Interim CAGR (5Y)9.21%

ROE (Last FY)-20.17%

Net Interest Coverage (Annual)-37.72x

EPS Basic Excl Extra (Annual)$-0.94

P/FCF (TTM)3.89x

Receivables Turnover (TTM)4.37x

EV / Free Cash Flow (TTM)4.96x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.69

Receivables Turnover (Annual)5.00x

ROI (TTM)-14.72%

P/S Ratio (TTM)2.21x

Pretax Margin (5Y Avg)-11.83%

Revenue / Share (Annual)$1.57

Tangible BV / Share (Annual)$4.57

Free OCF CAGR (5Y)117.00%

Price vs S&P 500 (52W)2.44%

Year-to-Date Return49.17%

5-Day Price Return-7.91%

EPS Normalized (Annual)$-0.94

ROA (5Y Avg)-3.81%

Net Profit Margin (Annual)-59.76%

Month-to-Date Return-7.91%

Cash Flow / Share (TTM)$0.96

EBITD / Share (Annual)$-0.90

Operating Margin (Annual)-62.57%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-4.67%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.69

P/TBV (Quarterly)1.03x

P/B Ratio (Annual)0.51x

Inventory Turnover (TTM)2.03x

Pretax Margin (TTM)-41.48%

Book Value / Share (Annual)$4.84

Price vs S&P 500 (13W)-9.40%

Beta1.09x

P/FCF (Annual)10.56x

Revenue / Share (TTM)$1.60

ROE (TTM)-14.73%

52-Week Low$2.08

vGradeA

gGradeD

mGradeC

vgmGradeC

OSUR Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 5, 2026	-$0.22	-$0.20	+9.09%(+$0.02)
Q1 2026	May 6, 2026	-$0.17	-$0.24	-45.00%(-$0.07)
Q4 2025	Feb 25, 2026	-$0.15	-$0.19	-24.82%(-$0.04)
Q3 2025	Nov 5, 2025	-$0.15	-$0.13	+13.88%(+$0.02)
Q2 2025	Aug 5, 2025	-$0.15	-$0.19	-26.23%(-$0.04)

OSUR Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.13

2.17

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
OSUROraSure Technologies Inc	A	D	C	2.2x	-7.7%	42.9%	-48.1%	$3.61
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About OraSure Technologies Inc

OraSure Technologies manufactures oral fluid diagnostic devices and specimen collection kits for infectious disease testing. The diagnostics segment provides rapid tests for HIV and HCV, while the larger molecular solutions segment offers collection and transport kits for genetic material and infectious disease screening, including COVID-19 testing. The company generates the majority of its revenue from molecular solutions, primarily serving U.S. customers.

OSUR Next Earnings Report

Report dateNov 4, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate-$0.18

Revenue estimate$31.14M

Also reporting on Nov 4, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

Companies in Related Industries

SMTISanara MedTech Inc. Common StockOrthopedic & Prosthetic Devices
OPTXSyntec Optics Holdings, Inc. Class A Common StockOptical Instruments & Lenses
NAUTNautilus Biotechnolgy, Inc. Common StockLab Analytical Instruments
EYPTEyePoint, Inc. Common StockLab Analytical Instruments
QSIQuantum-Si Incorporated Class A Common StockMeasuring & Controlling Devices
ELMDElectromed, Inc.Electromedical Equipment
GPROGoPro, Inc.Photographic Equipment & Supplies
FOCLEDAP TMS S.A. American Depositary SharesElectromedical Equipment

Same SIC sector, outside this company's own industry.

Analyst Sentiment

2.2

Sell

Consensus rating

52-Week Range

Low$2.08

High$4.58